|
|
|
|
|
|
|
Biondvax Pharma Ads (BVXV)
|
|
6.9 0.26 (3.92%)
|
05-18 16:00
|
|
Open:
|
6.76
|
Pre. Close:
|
6.64
|
|
High:
|
6.92
|
Low:
|
6.76
|
|
Volume:
|
16,286
|
Market Cap:
|
45M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
6.94 - 6.978
|
6.978 - 7.009
|
|
Low:
|
6.641 - 6.695
|
6.695 - 6.74
|
|
Close:
|
6.819 - 6.901
|
6.901 - 6.967
|
|
|
|
Technical analysis (as of: 2018-05-18 4:31:40 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 8.09 One year: 9.45
|
|
Support:
|
Support1: 6.34 Support2: 5.98
|
|
Resistance:
|
Resistance1:
6.93 Resistance2: 8.09
|
|
Pivot:
|
6.65 
|
|
Moving Averages:
|
MA(5): 6.76 MA(20): 6.57
MA(100): 6.26 MA(250): 6.96 
|
|
MACD:
|
MACD(12,26):
0.15 Signal(12,26,9): 0.14
|
|
%K %D:
|
%K(14,3): 85.21 %D(3): 79.08
|
|
RSI:
|
RSI(14): 59.92
|
|
52-Week:
|
High: 10.75
Low: 4.6 Change(%): -11.8
|
|
Average Vol(K):
|
3-Month: 1114
10-Days 663
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BVXV has closed below upper band by 27.1%. Bollinger Bands are 12.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-30T16:34:57-04:00
Biondvax Pharmaceuticals reports FY results
2018-04-30T16:05:00-04:00
BiondVax Announces Fourth Quarter and Full Year 2017 Financial Results and Update
2018-04-25T09:45:07-04:00
FDA accepts Sanofi Pasteur's marketing application for expanded use of flu vaccine
2018-04-13T09:56:25-04:00
Key events next week - healthcare
2018-04-12T06:30:00-04:00
BiondVax to Present at Universal Influenza Vaccines Conference
2018-04-11T12:07:40-04:00
BiondVax up 3% on start of mid-stage study of flu vaccine M-001
2018-04-11T07:45:00-04:00
BiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of Its Universal Flu Vaccine in the United States
2018-03-13T09:00:00-04:00
BiondVax Appoints CRO to Conduct Pivotal Clinical Efficacy Phase 3 Trial of Its Novel Universal Flu Vaccine Candidate
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
